Patient Portal

Keith E. Stockerl-Goldstein, MD

Associate Professor of Medicine,
Division of Oncology
Section of Bone Marrow Transplant

Specialty Areas

Bone Marrow Transplant
Amyloidosis
Multiple Myeloma
Hematologic Malignancies
Leukemia
Lymphoma
Myelodysplastic Syndrome
Oncology

Board Certifications

Medical Oncology
Internal Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Amyloidosis, blood and marrow transplantation, hematology, oncology, multiple myeloma, leukemia, lymphoma, medical informatics, myelodysplastic syndrome, stem cell transplant.

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Center for Advanced Medicine

4921 Parkview Place
St. Louis, MO 63110

Suite: B
Floor: 7
Office Phone: 314-454-8304
Fax: 314-454-7551

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129
Phone: 314-747-7222

Office Phone: 314-454-8304

Education

Education

Fellowship: Bone Marrow Transplantation, Stanford University School of Medicine, Stanford, California 1995
Fellowship: Medical Oncology, Stanford University, Stanford, California 1996
Residency: Internal Medicine, Stanford University Hospital, Stanford, California 1993
M.D.: UCLA School of Medicine, Los Angeles, California 1991
B.A.: Biology, Washington University, Saint Louis, Missouri 1986

Publication & Research

Publication & Research

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.
Richardson PG, Bensinger WI, Huff CA, Costello CL, Lendvai N, Berdeja JG, Anderson LD Jr, Siegel DS, Lebovic D, Jagannath S, Laubach JP, Stockerl-Goldstein KE, Kwei L, Clow F, Elias L, Salman Z, Graef T, Bilotti E, Vij R
Br J Haematol. 2018 Mar; 180(6)821-830. doi: 10.1111/bjh.15058.

PMID:
    29435979
    [PubMed - in process]
Related citations


Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.
Ali AM, Weisel D, Gao F, Uy GL, Cashen AF, Jacoby MA, Wartman LD, Ghobadi A, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein KE, Vij R, Oh ST, Abboud CN, Schroeder MA, Westervelt P, DiPersio JF, Welch JS
Cancer Med. 2017 Dec; 6(12)2814-2821. doi: 10.1002/cam4.1231.

PMID:
    29058375
    [PubMed - indexed for MEDLINE]
Related citations


TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Welch JS, Petti AA, Miller CA, Fronick CC, O'Laughlin M, Fulton RS, Wilson RK, Baty JD, Duncavage EJ, Tandon B, Lee YS, Wartman LD, Uy GL, Ghobadi A, Tomasson MH, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein KE, Vij R, Oh ST, Abboud CN, Cashen AF, Schroeder MA, Jacoby MA, Heath SE, Luber K, Janke MR, Hantel A, Khan N, Sukhanova MJ, Knoebel RW, Stock W, Graubert TA, Walter MJ, Westervelt P, Link DC, DiPersio JF, Ley TJ
N Engl J Med. 2016 Nov 24; 375(21)2023-2036. doi: 10.1056/NEJMoa1605949.

PMID:
    27959731
    [PubMed - indexed for MEDLINE]
Related citations


Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.
Nedved AN, DeFrates SR, Hladnik LM, Stockerl-Goldstein KE
Pharmacotherapy. 2016 Oct; 36(10)1087-1094. doi: 10.1002/phar.1824.

PMID:
    27521990
    [PubMed - indexed for MEDLINE]
Related citations


Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantation.
Fiala MA, Park S, Slade M, DiPersio JF, Stockerl-Goldstein KE
Transfusion. 2016 Sep; 56(9)2331-5. doi: 10.1111/trf.13688.

PMID:
    27311884
    [PubMed - indexed for MEDLINE]
Related citations


A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia.
Wartman LD, Fiala MA, Fletcher T, Hawkins ER, Cashen A, DiPersio JF, Jacoby MA, Stockerl-Goldstein KE, Pusic I, Uy GL, Westervelt P, Vij R
Leuk Lymphoma. 2016; 57(3)728-30. doi: 10.3109/10428194.2015.1076930.

PMID:
    26674111
    [PubMed - indexed for MEDLINE]
Related citations


Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome.
Pusic I, Choi J, Fiala MA, Gao F, Holt M, Cashen AF, Vij R, Abboud CN, Stockerl-Goldstein KE, Jacoby MA, Uy GL, Westervelt P, DiPersio JF
Biol Blood Marrow Transplant. 2015 Oct; 21(10)1761-9. doi: 10.1016/j.bbmt.2015.05.026.

PMID:
    26055299
    [PubMed - indexed for MEDLINE]
Related citations


Hematologic Recovery after Pretransplant Chemotherapy Does Not Influence Survival after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients.
Vu K, Manjappa S, DiPersio JF, Gao F, Westervelt P, Vij R, Stockerl-Goldstein KE, Uy GL, Abboud CN, Schroeder MA, Fehniger TA, Cashen AF, Romee R
Biol Blood Marrow Transplant. 2015 Aug; 21(8)1425-30. doi: 10.1016/j.bbmt.2015.03.022.

PMID:
    25840336
    [PubMed - indexed for MEDLINE]
Related citations


Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma.
Fiala MA, Finney JD, Stockerl-Goldstein KE, Tomasson MH, DiPersio JF, Vij R, Wildes TM
Biol Blood Marrow Transplant. 2015 Jul; 21(7)1153-4. doi: 10.1016/j.bbmt.2015.03.005.

PMID:
    25771403
    [PubMed - indexed for MEDLINE]
Related citations


Socioeconomic status is independently associated with overall survival in patients with multiple myeloma.
Fiala MA, Finney JD, Liu J, Stockerl-Goldstein KE, Tomasson MH, Vij R, Wildes TM
Leuk Lymphoma. 2015; 56(9)2643-9. doi: 10.3109/10428194.2015.1011156.

PMID:
    25651424
    [PubMed - indexed for MEDLINE]
Related citations


A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma.
Wang TF, Fiala MA, Cashen AF, Uy GL, Abboud CN, Fletcher T, Wu N, Westervelt P, DiPersio JF, Stockerl-Goldstein KE, Vij R
Bone Marrow Transplant. 2014 Nov; 49(11)1366-70. doi: 10.1038/bmt.2014.163.

PMID:
    25068418
    [PubMed - indexed for MEDLINE]
Related citations


A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.
Welch JS, Niu H, Uy GL, Westervelt P, Abboud CN, Vij R, Stockerl-Goldstein KE, Jacoby M, Pusic I, Schroeder MA, Dipersio JF, Cashen AF
Am J Hematol. 2014 Aug; 89(8)E103-8. doi: 10.1002/ajh.23735.

PMID:
    24723466
    [PubMed - indexed for MEDLINE]
Related citations


The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide.
Wang TF, Ahluwalia R, Fiala MA, Trinkaus KM, Cox DP, Jaenicke M, Moliske CC, Carson KR, Wildes TM, Tomasson MH, Stockerl-Goldstein KE, Vij R
Leuk Lymphoma. 2014 Feb; 55(2)337-41. doi: 10.3109/10428194.2013.803547.

PMID:
    23662990
    [PubMed - indexed for MEDLINE]
Related citations


A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.
Uy GL, Rettig MP, Motabi IH, McFarland K, Trinkaus KM, Hladnik LM, Kulkarni S, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Vij R, Westervelt P, DiPersio JF
Blood. 2012 Apr 26; 119(17)3917-24. doi: 10.1182/blood-2011-10-383406.

PMID:
    22308295
    [PubMed - indexed for MEDLINE]
Related citations


Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literature.
Chawla JS, Ghobadi A, Mosley J 3rd, Verkruyse L, Trinkaus K, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Uy GL, Westervelt P, DiPersio JF, Vij R
Transpl Infect Dis. 2012 Jun; 14(3)259-67. doi: 10.1111/j.1399-3062.2011.00689.x.

PMID:
    22093134
    [PubMed - indexed for MEDLINE]
Related citations


Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study.
Welch JS, Klco JM, Gao F, Procknow E, Uy GL, Stockerl-Goldstein KE, Abboud CN, Westervelt P, DiPersio JF, Hassan A, Cashen AF, Vij R
Am J Hematol. 2011 Sep; 86(9)796-800. doi: 10.1002/ajh.22092.

PMID:
    21815182
    [PubMed - indexed for MEDLINE]
Related citations


Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells.
Müller AM, Kohrt HE, Cha S, Laport G, Klein J, Guardino AE, Johnston LJ, Stockerl-Goldstein KE, Hanania E, Juttner C, Blume KG, Negrin RS, Weissman IL, Shizuru JA
Biol Blood Marrow Transplant. 2012 Jan; 18(1)125-33. doi: 10.1016/j.bbmt.2011.07.009.

PMID:
    21767515
    [PubMed - indexed for MEDLINE]
Related citations


Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation.
Smeltzer JP, Cashen AF, Zhang Q, Homb A, Dehdashti F, Abboud CN, Dipersio JF, Stockerl-Goldstein KE, Uy GL, Vij R, Westervelt P, Bartlett NL, Fehniger TA
Biol Blood Marrow Transplant. 2011 Nov; 17(11)1646-52. doi: 10.1016/j.bbmt.2011.04.011.

PMID:
    21601641
    [PubMed - indexed for MEDLINE]
Related citations


A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia.
Fehniger TA, Uy GL, Trinkaus K, Nelson AD, Demland J, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Westervelt P, DiPersio JF, Vij R
Blood. 2011 Feb 10; 117(6)1828-33. doi: 10.1182/blood-2010-07-297143.

PMID:
    21051557
    [PubMed - indexed for MEDLINE]
Related citations


A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sézary syndrome.
Wu PA, Kim YH, Lavori PW, Hoppe RT, Stockerl-Goldstein KE
Biol Blood Marrow Transplant. 2009 Aug; 15(8)982-90. doi: 10.1016/j.bbmt.2009.04.017.

PMID:
    19589488
    [PubMed - indexed for MEDLINE]
Related citations